• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

梗阻性肥厚型心肌病经皮心内间隔射频消融术后心肌灌注改善及机制:心肌对比超声心动图研究

Myocardial perfusion improvement and mechanism after percutaneous intramyocardial septal radiofrequency ablation in obstructive hypertrophic cardiomyopathy: a study of myocardial contrast echocardiography.

作者信息

Yao Lu, Ta Shengjun, Wang Jing, Han Chao, Lei Changhui, Li Wenxia, Li Jing, Wang Bo, Zhao Xueli, Liu Liwen

机构信息

Department of Ultrasound, Xijing Hypertrophic Cardiomyopathy Center, Xijing Hospital, Air Force Military Medical University, 127 Changle West Road, Xi'an, 710032, Shaanxi, China.

出版信息

Int J Cardiovasc Imaging. 2024 Jul;40(7):1483-1492. doi: 10.1007/s10554-024-03126-7. Epub 2024 May 6.

DOI:10.1007/s10554-024-03126-7
PMID:38709352
Abstract

The data on myocardial perfusion of the percutaneous intramyocardial septal radiofrequency ablation (PIMSRA) for obstructive hypertrophic cardiomyopathy (HOCM) are still lacking, although PIMSRA have been proved to be of great safety and efficacy. The aim of this study was to quantitatively analyze the changes in myocardial perfusion after PIMSRA using myocardial contrast echocardiography (MCE). 27 HOCM patients treated with PIMSRA were retrospectively analyzed, and their echocardiographic parameters and perfusion parameters of MCE were collected before and 12 months after PIMSRA. A reperfusion curve was used to quantify microvascular blood volume (A), microvascular flux rate (β), and microvascular blood flow (MBF) of each segment. Then the value difference (Δ) of parameters between post- and pre-operation were calculated. Finally, the correlation between the changes in MBF and in each echocardiographic parameter was analyzed. (1) Compared with baseline, the global A, β and MBF were significantly increased in HOCM patients after PIMSRA (all P < 0.001). The β, MBF were increased in the interventricular septum (P < 0.001, respectively), and the A, β, MBF were increased in the left ventricular wall (all P < 0.001). (2) Correlation analysis showed that the ΔMBF of interventricular septum was mainly negatively correlated with the maximum interventricular septum thickness (ΔIVSTmax, r=-0.670, P < 0.001), mean interventricular septum thickness (ΔIVSTmean, r=-0.690, P < 0.001), and left ventricular mass index (ΔLVMI, r=-0.774, P < 0.001), while the ΔMBF of left ventricular wall was positively correlated with left ventricular end-diastolic volume index (ΔLVEDVI, r = 0.621, P = 0.001) and stroke volume index (ΔSVI, r = 0.810, P < 0.001). Myocardial perfusion was improved at both interventricular septum and ventricular wall in HOCM patients after PIMSRA. MCE can provide a new dimension for the efficacy evaluation to PIMSRA procedure.

摘要

尽管经皮心肌间隔射频消融术(PIMSRA)已被证明具有很高的安全性和有效性,但关于其治疗梗阻性肥厚型心肌病(HOCM)的心肌灌注数据仍然缺乏。本研究的目的是使用心肌对比超声心动图(MCE)定量分析PIMSRA术后心肌灌注的变化。回顾性分析27例接受PIMSRA治疗的HOCM患者,收集其PIMSRA术前和术后12个月的超声心动图参数及MCE灌注参数。采用再灌注曲线定量分析各节段的微血管血容量(A)、微血管流速(β)和微血管血流量(MBF)。然后计算术后与术前参数的差值(Δ)。最后,分析MBF变化与各超声心动图参数变化之间的相关性。(1)与基线相比,PIMSRA术后HOCM患者的整体A、β和MBF均显著增加(均P < 0.001)。室间隔的β、MBF增加(分别为P < 0.001),左心室壁的A、β、MBF增加(均P < 0.001)。(2)相关性分析显示,室间隔的ΔMBF主要与室间隔最大厚度(ΔIVSTmax,r=-0.670,P < 0.001)、室间隔平均厚度(ΔIVSTmean,r=-0.690,P < 0.001)和左心室质量指数(ΔLVMI,r=-0.774,P < 0.001)呈负相关,而左心室壁的ΔMBF与左心室舒张末期容积指数(ΔLVEDVI,r = 0.621,P = 0.001)和每搏输出量指数(ΔSVI,r = 0.810,P < 0.001)呈正相关。PIMSRA术后HOCM患者的室间隔和心室壁心肌灌注均得到改善。MCE可为PIMSRA手术的疗效评估提供一个新的维度。

相似文献

1
Myocardial perfusion improvement and mechanism after percutaneous intramyocardial septal radiofrequency ablation in obstructive hypertrophic cardiomyopathy: a study of myocardial contrast echocardiography.梗阻性肥厚型心肌病经皮心内间隔射频消融术后心肌灌注改善及机制:心肌对比超声心动图研究
Int J Cardiovasc Imaging. 2024 Jul;40(7):1483-1492. doi: 10.1007/s10554-024-03126-7. Epub 2024 May 6.
2
[Efficacy and safety of transthoracic echocardiography-guided percutaneous intramyocardial septal radiofrequency ablation for the treatment of patients with obstructive hypertrophic cardiomyopathy].经胸超声心动图引导下经皮心肌间隔射频消融术治疗梗阻性肥厚型心肌病患者的疗效与安全性
Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Apr 24;47(4):284-290. doi: 10.3760/cma.j.issn.0253-3758.2019.04.005.
3
Midterm Outcomes of Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Cardiomyopathy: A Single-Center, Observational Study.经皮心肌内射频消融治疗肥厚型心肌病的中期结果:单中心观察性研究。
J Am Heart Assoc. 2024 Aug 6;13(15):e034080. doi: 10.1161/JAHA.123.034080. Epub 2024 Jul 26.
4
Clinical value of 2D speckle tracking imaging in evaluating the effect of percutaneous intramyocardial septal radiofrequency ablation in patients with hypertrophic obstructive cardiomyopathy.二维斑点追踪成像技术评价经皮心肌内室间隔射频消融术治疗肥厚型梗阻性心肌病的临床价值。
J Clin Ultrasound. 2021 Jul;49(6):554-562. doi: 10.1002/jcu.22989. Epub 2021 Mar 6.
5
Analysis of risk factors for complications in echocardiography-guided percutaneous intramyocardial septal radiofrequency ablation.超声心动图引导下经皮心肌内间隔射频消融术并发症的危险因素分析
J Cardiothorac Surg. 2024 Jul 16;19(1):454. doi: 10.1186/s13019-024-02934-1.
6
Myocardial mechanics of percutaneous intramyocardial septal radiofrequency ablation.经皮心内膜间隔射频消融术的心肌力学
Heart. 2023 Jan 27;109(4):289-296. doi: 10.1136/heartjnl-2022-321597.
7
Percutaneous intramyocardial septal radiofrequency ablation after 5-year follow-up.经皮心肌内间隔射频消融术后 5 年随访。
Heart. 2024 May 10;110(11):792-799. doi: 10.1136/heartjnl-2023-323606.
8
Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy.经皮心肌内室间隔射频消融治疗肥厚型梗阻性心肌病。
J Am Coll Cardiol. 2018 Oct 16;72(16):1898-1909. doi: 10.1016/j.jacc.2018.07.080.
9
Myocardial perfusion after percutaneous transluminal septal myocardial ablation as assessed by myocardial contrast echocardiography in patients with hypertrophic obstructive cardiomyopathy.经皮腔内室间隔心肌消融术后心肌灌注的心肌对比超声心动图评估:肥厚型梗阻性心肌病患者的研究
J Am Soc Echocardiogr. 2006 Aug;19(8):982-6. doi: 10.1016/j.echo.2006.03.018.
10
Short time effects of two radiofrequency ablation methods on hypertrophic obstructive cardiomyopathy.两种射频消融方法对肥厚型梗阻性心肌病的短期疗效。
Clin Cardiol. 2024 Feb;47(3):e24217. doi: 10.1002/clc.24217.

引用本文的文献

1
Efficacy and safety of radiofrequency ablation for hypertrophic obstructive cardiomyopathy: a meta-analysis.射频消融治疗肥厚型梗阻性心肌病的疗效与安全性:一项荟萃分析。
Future Cardiol. 2025 Jun;21(8):611-619. doi: 10.1080/14796678.2025.2509368. Epub 2025 May 22.

本文引用的文献

1
Microvascular Dysfunction in Hypertrophic Cardiomyopathy.肥厚型心肌病中的微血管功能障碍
J Clin Med. 2022 Nov 4;11(21):6560. doi: 10.3390/jcm11216560.
2
Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy.经皮心肌内室间隔射频消融治疗药物难治性肥厚梗阻性心肌病。
JAMA Cardiol. 2022 May 1;7(5):529-538. doi: 10.1001/jamacardio.2022.0259.
3
Diagnosis and Evaluation of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review.肥厚型心肌病的诊断与评估:美国心脏病学会心血管造影与介入学会最新临床综述
J Am Coll Cardiol. 2022 Feb 1;79(4):372-389. doi: 10.1016/j.jacc.2021.12.002.
4
Mechanobiology of Microvascular Function and Structure in Health and Disease: Focus on the Coronary Circulation.健康与疾病状态下微血管功能和结构的力学生物学:聚焦于冠状动脉循环
Front Physiol. 2021 Dec 23;12:771960. doi: 10.3389/fphys.2021.771960. eCollection 2021.
5
Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases: JACC State-of-the-Art Review.冠状动脉微血管功能障碍在心血管疾病谱中的表现:美国心脏病学会最新综述。
J Am Coll Cardiol. 2021 Sep 28;78(13):1352-1371. doi: 10.1016/j.jacc.2021.07.042.
6
Predicting the clinical course in hypertrophic cardiomyopathy using thallium-201 myocardial scintigraphy.使用铊-201心肌闪烁显像术预测肥厚型心肌病的临床病程。
ESC Heart Fail. 2021 Apr;8(2):1378-1387. doi: 10.1002/ehf2.13218. Epub 2021 Feb 12.
7
Small Vessel Disease: Another Component of the Hypertrophic Cardiomyopathy Phenotype Not Necessarily Associated with Fibrosis.小血管疾病:肥厚型心肌病表型的另一个组成部分,不一定与纤维化相关。
J Clin Med. 2021 Feb 4;10(4):575. doi: 10.3390/jcm10040575.
8
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020 年 AHA/ACC 肥厚型心肌病患者诊断与治疗指南:概要:美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
J Am Coll Cardiol. 2020 Dec 22;76(25):3022-3055. doi: 10.1016/j.jacc.2020.08.044. Epub 2020 Nov 20.
9
Contrast echocardiography: current status and future directions.对比超声心动图:现状与未来方向。
Heart. 2021 Jan;107(1):18-24. doi: 10.1136/heartjnl-2020-316662. Epub 2020 Oct 19.
10
Contrast-Enhanced Echocardiographic Measurement of Left Ventricular Wall Thickness in Hypertrophic Cardiomyopathy: Comparison with Standard Echocardiography and Cardiac Magnetic Resonance.对比增强超声心动图测量肥厚型心肌病左心室壁厚度:与标准超声心动图和心脏磁共振的比较。
J Am Soc Echocardiogr. 2020 Sep;33(9):1106-1115. doi: 10.1016/j.echo.2020.04.009. Epub 2020 Jun 18.